Dysregulated ADAM10 activity is assumed to play a central role in diverse pathologies including Alzheimer’s disease, allergic responses, and cancer development (Weskamp et al., 2006; Murphy, 2008; Marcello et al., 2017). The gene discussed is ADAM10; the disease is early-onset autosomal dominant Alzheimer disease.